Responses
Oral Presentations
Progress in biological treatment of RA
OP0099 Safety, tolerability and initial signs of efficacy of the fully human immunocytokine DEKAVIL (F8IL10): a novel therapeutic approach for rheumatoid arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.